Barclays
CANO

Barclays’s Cano Health, Inc. CANO Stock Holding History

Barclays’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,599
Closed -$21.1K – 5495
2023
Q4 		$21.1K Buy
3,599
+2,402
+201% +$28.4K ﹤0.01% 4899
2023
Q3 		$30.3K Sell
1,197
-5,161
-81% -$424K ﹤0.01% 4055
2023
Q2 		$884K Buy
6,358
+254
+4% +$32.6K ﹤0.01% 2387
2023
Q1 		$555K Buy
6,104
+5,384
+748% +$731K ﹤0.01% 3193
2022
Q4 		$98.6K Sell
720
-15,684
-96% -$5.31M ﹤0.01% 4229
2022
Q3 		$14.2M Sell
16,404
-461
-3% -$289K 0.02% 726
2022
Q2 		$7.39M Sell
16,865
-6,693
-28% -$3.49M ﹤0.01% 1140
2022
Q1 		$15M Buy
+23,558
New +$14.9M 0.01% 784

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $10.6B AUM 19.99% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $306M AUM 24.15% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $195M AUM 15.9% 1-Year Est. Return